Adjuvant radiotherapy shows benefit in selected stage I uterine sarcoma: A risk scoring system based on a population analysis.
Yun-Xia HuangYan-Zong LinYi-Min LiKe-Xin ChuYu-Fei ZhouLi-Mei LinRui ZhouZong-Kai ZhangQin LinPublished in: Cancer medicine (2022)
Our risk scoring model based on stage, tumor grade, and histology predicted the outcome of patients with stage I uterine sarcoma cancer. This system may help to select stage I uterine sarcoma cancer patients who might benefit from adjuvant radiotherapy.